Atlas Trials

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Clinical trial NCT02608060 · TERMINATED

Trial details

NCT number
NCT02608060
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Anemia
Start date
2006-09-01
Primary completion
2007-10-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.